Disclosed is a lipase inhibitor which can be ingested safely by blending it into a pharmaceutical product or food, which contains, as an active ingredient, an extract separated from a food raw material or a compound contained in a plant, and which is useful for the prevention/treatment of a lifestyle-related disease or metabolic syndrome. The lipase inhibitor comprises myricitrin as an active ingredient.
